Bacteriophage therapy for refractory Pseudomonas aeruginosa urinary tract infection

Journal of Medical Microbiology

Volumn 60, Issue 11, 2011, Pages 1697-1700

  Khawaldeh, A ^a   Morales, S ^b   Dillon, B ^a   Alavidze, Z ^c   Ginn, A N ^a   Thomas, L ^a   Chapman, S J ^a   Dublanchet, A ^d   Smithyman, A ^b   Iredell, J R ^a,e  

^a SYDNEY SOUTH WEST AREA HEALTH SERVICE   (Australia)

^b Special Phage Services Pty   (Australia)

^c George Eliava Institute of Bacteriophage Microbiology and Virology   (Georgia)

^d Centre Hospitalier Intercommunal de Villeneuve Saint Georges   (France)

^e UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; GENTAMICIN; MEROPENEM; PROBIOTIC AGENT; PYOPHAGE; UNCLASSIFIED DRUG;

ABDOMINAL CANCER; ABDOMINAL SURGERY; ADENOCARCINOMA; AGED; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIOPHAGE; BACTERIUM CULTURE; BACTERIUM ISOLATE; CANCER RADIOTHERAPY; CANCER SURGERY; CASE REPORT; CYSTOSCOPY; DNA FINGERPRINTING; DRUG TREATMENT FAILURE; ENTEROCOCCUS FAECALIS; EPSILOMETER TEST; ESCHERICHIA COLI; FEMALE; HEMATURIA; HUMAN; INTERSTITIAL CYSTITIS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; PYURIA; RECURRENT CANCER; RELAPSE; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; TREATMENT DURATION; URETER STENT; URETER STRICTURE; URINALYSIS; URINARY TRACT INFECTION; URINE CULTURE;

AGED; BACTERIOPHAGES; COLONY COUNT, MICROBIAL; DNA, BACTERIAL; FEMALE; HUMANS; POLYMERASE CHAIN REACTION; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RNA, RIBOSOMAL, 16S; URINARY TRACT INFECTIONS;

EID: 80054724924     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.029744-0     Document Type: Article

References (12)

1. Azeredo, J. & Sutherland, I. W. (2008). The use of phages for the removal of infectious biofilms. Curr Pharm Biotechnol 9, 261-266.
2. Fothergill, J. L., Mowat, E., Ledson, M. J., Walshaw, M. J. & Winstanley, C. (2010). Fluctuations in phenotypes and genotypes within populations of Pseudomonas aeruginosa in the cystic fibrosis lung during pulmonary exacerbations. J Med Microbiol 59, 472-481.
3. Harper, D. R. & Enright, M. C. (2011). Bacteriophages for the treatment of Pseudomonas aeruginosa infections. J Appl Microbiol 111, 1-7.
4. Himmelweit, F. (1945). Combined action of penicillin and bacterio- phage on Staphylococci. Lancet 246, 104-105.
5. Kutter, E., De Vos, D., Gvasalia, G., Alavidze, Z., Gogokhia, L., Kuhl, S. & Abedon, S. T. (2010). Phage therapy in clinical practice: treatment of human infections. Curr Pharm Biotechnol 11, 69-86.
6. Marza, J. A., Soothill, J. S., Boydell, P. & Collyns, T. A. (2006). Multiplication of therapeutically administered bacteriophages in Pseudomonas aeruginosa infected patients. Burns 32, 644-646.
7. Rhoads, D. D., Wolcott, R. D., Kuskowski, M. A., Wolcott, B. M., Ward, L. S. & Sulakvelidze, A. (2009). Bacteriophage therapy of venous leg ulcers in humans: results of a phase I safety trial. J Wound Care 18, 237-238, 240-243.
8. Stone, R. (2002). Bacteriophage therapy. Stalin's forgotten cure. Science 298, 728-731.
9. Sulakvelidze, A., Alavidze, Z. & Morris, J. G., Jr (2001). Bacteriophage therapy. Antimicrob Agents Chemother 45, 649-659.
10. Szewczuk, E., Thapa, K., Anninos, T., McPhie, K., Higgins, G., Dwyer, D. E., Stanley, K. K. & Iredell, J. R. (2010). Rapid semi-automated quantitative multiplex tandem PCR (MT-PCR) assays for the differential diagnosis of influenza-like illness. BMC Infect Dis 10, 113.
11. Versalovic, J., Koeuth, T. & Lupski, J. R. (1991). Distribution of repetitive DNA sequences in eubacteria and application to fingerprinting of bacterial genomes. Nucleic Acids Res 19, 6823-6831.
12. Wright, A., Hawkins, C. H., Angga rd, E. E. & Harper, D. R. (2009). A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic-resistant Pseudomonas aeruginosa; a preliminary report of efficacy. Clin Otolaryngol 34, 349-357.